Domperidone

This classification denotes an antipsychotic agent with the molecular formula C22H24ClN5O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 5587267Z69, chemically known as 5-chloro-1-(1-(3-(2-oxo-2,3-dihydro-1h-benzimidazol-1-yl)propyl)-4-piperidinyl)-1,3-dihydro-2h-benzimidazol-2-one but generally known as domperidone, which bears US NIH Compound Identifier 3151. European Medicines Agency schedules Domperidone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06361MIG. The term DOMPERIDONE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 31, No10, 1977, List 17). World Health Organization schedules domperidone in its Anatomical Therapeutic Chemical (ATC) Classification. DOMPERIDONE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule domperidone under HS 29333999 and SITC 51574. As of Q4 2014, DOMPERIDONE remains the US FDA Preferred Term for this commodity. Domperidone bears US NLM identifiers UMLS ID C0013015 and NCI Concept Code C454. SMILES: CLC1CC2[NH]C(=O)N(C3CCN(CC3)CCCN3C4C([NH]C3=O)CCCC4)C2CC1.